2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+))

C150H106N11O2PPt2 — CID 159394430

IUPAC2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+))
SMILESCc1c[c-]c(-c2ncco2)c(C)c1-c1ccc(-c2ccccc2)cc1.Cc1cc(-c2ccccc2)cc(C)c1-c1cc[c-]c(-c2nccn2C)c1.O=P1(c2ccccc2)c2ccccc2-c2ccc(-c3cc(-c4[c-]cccc4)[n-]n3)cc21.[Pt+4].[Pt+4].[c-]1ccccc1-c1cc(-c2ccc3c(c2)C2(c4ccccc4-c4ccccc42)c2ccccc2-3)n[n-]1.[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1
InChIInChI=1S/C34H20N2.C27H17N2OP.C24H21N2.C23H18NO.2C21H15N2.2Pt/c1-2-10-22(11-3-1)32-21-33(36-35-32)23-18-19-27-26-14-6-9-17-30(26)34(31(27)20-23)28-15-7-4-12-24(28)25-13-5-8-16-29(25)34;30-31(21-11-5-2-6-12-21)26-14-8-7-13-22(26)23-16-15-20(17-27(23)31)25-18-24(28-29-25)19-9-3-1-4-10-19;1-17-14-22(19-8-5-4-6-9-19)15-18(2)23(17)20-10-7-11-21(16-20)24-25-12-13-26(24)3;1-16-8-13-21(23-24-14-15-25-23)17(2)22(16)20-11-9-19(10-12-20)18-6-4-3-5-7-18;2*1-3-7-17(8-4-1)18-11-13-19(14-12-18)20-15-22-23(16-20)21-9-5-2-6-10-21;;/h1-10,12-21H;1-9,11-18H;4-10,12-16H,1-3H3;3-12,14-15H,1-2H3;2*1-9,11-16H;;/q2*-2;4*-1;2*+4
InChIKeyGOYBSHRZMNAXSP-UHFFFAOYSA-N
MW2515.70 g/mol
LogP34.25
Rot. Bonds17

About 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+))

2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+)) (PubChem CID 159394430) has the molecular formula C150H106N11O2PPt2 and a molecular weight of 2515.70 g/mol. Its IUPAC name is 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+)).

Molecular Properties

Compound Name2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+))
PubChem CID159394430
Molecular FormulaC150H106N11O2PPt2
Molecular Weight2515.70 g/mol
Exact Mass2513.76
IUPAC Name2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+))
SMILESCc1c[c-]c(-c2ncco2)c(C)c1-c1ccc(-c2ccccc2)cc1.Cc1cc(-c2ccccc2)cc(C)c1-c1cc[c-]c(-c2nccn2C)c1.O=P1(c2ccccc2)c2ccccc2-c2ccc(-c3cc(-c4[c-]cccc4)[n-]n3)cc21.[Pt+4].[Pt+4].[c-]1ccccc1-c1cc(-c2ccc3c(c2)C2(c4ccccc4-c4ccccc42)c2ccccc2-3)n[n-]1.[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1
InChIInChI=1S/C34H20N2.C27H17N2OP.C24H21N2.C23H18NO.2C21H15N2.2Pt/c1-2-10-22(11-3-1)32-21-33(36-35-32)23-18-19-27-26-14-6-9-17-30(26)34(31(27)20-23)28-15-7-4-12-24(28)25-13-5-8-16-29(25)34;30-31(21-11-5-2-6-12-21)26-14-8-7-13-22(26)23-16-15-20(17-27(23)31)25-18-24(28-29-25)19-9-3-1-4-10-19;1-17-14-22(19-8-5-4-6-9-19)15-18(2)23(17)20-10-7-11-21(16-20)24-25-12-13-26(24)3;1-16-8-13-21(23-24-14-15-25-23)17(2)22(16)20-11-9-19(10-12-20)18-6-4-3-5-7-18;2*1-3-7-17(8-4-1)18-11-13-19(14-12-18)20-15-22-23(16-20)21-9-5-2-6-10-21;;/h1-10,12-21H;1-9,11-18H;4-10,12-16H,1-3H3;3-12,14-15H,1-2H3;2*1-9,11-16H;;/q2*-2;4*-1;2*+4
InChIKeyGOYBSHRZMNAXSP-UHFFFAOYSA-N
XLogP34.25
TPSA150.54 Ų
H-Bond Donors
H-Bond Acceptors11
Rotatable Bonds17
Heavy Atoms166
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002515.70
LogP ≤ 534.25
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+))?
The IUPAC name of 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+)) (CID 159394430) is 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+)).
What is the SMILES notation for 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+))?
The canonical SMILES for 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+)) is Cc1c[c-]c(-c2ncco2)c(C)c1-c1ccc(-c2ccccc2)cc1.Cc1cc(-c2ccccc2)cc(C)c1-c1cc[c-]c(-c2nccn2C)c1.O=P1(c2ccccc2)c2ccccc2-c2ccc(-c3cc(-c4[c-]cccc4)[n-]n3)cc21.[Pt+4].[Pt+4].[c-]1ccccc1-c1cc(-c2ccc3c(c2)C2(c4ccccc4-c4ccccc42)c2ccccc2-3)n[n-]1.[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.
What is the InChIKey of 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+))?
The InChIKey is GOYBSHRZMNAXSP-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H20N2.C27H17N2OP.C24H21N2.C23H18NO.2C21H15N2.2Pt/c1-2-10-22(11-3-1)32-21-33(36-35-32)23-18-19-27-26-14-6-9-17-30(26)34(31(27)20-23)28-15-7-4-12-24(28)25-13-5-8-16-29(25)34;30-31(21-11-5-2-6-12-21)26-14-8-7-13-22(26)23-16-15-20(17-27(23)31)25-18-24(28-29-25)19-9-3-1-4-10-19;1-17-14-22(19-8-5-4-6-9-19)15-18(2)23(17)20-10-7-11-21(16-20)24-25-12-13-26(24)3;1-16-8-13-21(23-24-14-15-25-23)17(2)22(16)20-11-9-19(10-12-20)18-6-4-3-5-7-18;2*1-3-7-17(8-4-1)18-11-13-19(14-12-18)20-15-22-23(16-20)21-9-5-2-6-10-21;;/h1-10,12-21H;1-9,11-18H;4-10,12-16H,1-3H3;3-12,14-15H,1-2H3;2*1-9,11-16H;;/q2*-2;4*-1;2*+4.
What are the key properties of 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+))?
2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+)) has a molecular weight of 2515.70 g/mol, XLogP of 34.25, 17 rotatable bonds, 0 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-1-methylimidazole;2-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-1,3-oxazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);5-phenyl-3-(5-phenylpyrazol-1-id-3-yl)benzo[b]phosphindole 5-oxide;5-phenyl-3-(9,9'-spirobi[fluorene]-2-yl)pyrazol-1-ide;bis(platinum(4+)) is sourced from PubChem (CID 159394430), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).